Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEupraxia Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.30 | -$0.23 | -$0.26 |
| Q2 2026 | 4 | -$0.28 | -$0.25 | -$0.27 |
| Q3 2026 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2026 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2027 | 2 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2027 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q3 2027 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q4 2027 | 2 | -$0.28 | -$0.28 | -$0.28 |
| Q1 2028 | 3 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2028 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2028 | 2 | -$0.81 | -$0.81 | -$0.81 |
| Q4 2028 | 3 | -$1.06 | -$1.06 | -$1.06 |
Eupraxia Pharmaceuticals Inc Earnings Date And Information
Eupraxia Pharmaceuticals Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.22669 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22 by $0.00669. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Eupraxia Pharmaceuticals Inc has generated $-1 earnings per share over the last year ($-1.05 diluted earnings per share) and currently has a price-to-earnings ratio of -9.61. Eupraxia Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Eupraxia Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 2025 | N/A | -$0.34 | N/A | $0 | $0 |
| 11/04/2025 | Q3 2025 | -$0.23 | -$0.19 | 0.04 | $0 | $0 |
| 08/12/2025 | Q2 2025 | N/A | -$0.33 | N/A | N/A | $0 |
| 05/06/2025 | Q1 2025 | -$0.19 | -$0.30 | -0.11 | N/A | $0 |
| 03/20/2025 | Q4 2024 | -$0.18 | -$0.21 | -0.03 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.13 | -$0.17 | -0.04 | N/A | $0 |
| 08/07/2024 | Q2 2024 | -$0.17 | -$0.17 | -0 | N/A | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$0.21 | N/A | N/A | $0 |
| 04/01/2024 | Q4 2023 | N/A | -$0.15 | N/A | N/A | $0 |
| 01/01/2024 | Q3 2023 | N/A | -$0.41 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.43 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.18 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.41 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.22 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.31 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.26 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | -$0.30 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$0.35 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.41 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.68 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eupraxia Pharmaceuticals Inc Earnings: FAQ's
The conference call for Eupraxia Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Eupraxia Pharmaceuticals Inc's latest earnings report can be read online.
Eupraxia Pharmaceuticals Inc (:EPRX) has a recorded net income of $-38,576,143.Eupraxia Pharmaceuticals Inc has generated $-1.05 earnings per share over the last four quarters.
Eupraxia Pharmaceuticals Inc (:EPRX) has a price-to-earnings ratio of -9.61 and price/earnings-to-growth ratio is 0.28.